UnitedHealth Group (LIM:UNH) EBITDA Margin %: 8.90% (As of Mar. 2026) — Near Median


LIM:UNH UnitedHealth Group Inc LIM:UNH
66 GF Score
Price $415.00
GF Value $603.41
Valuation Significantly Undervalued
! 10 Warning Signs
View Full Analysis

What is UnitedHealth Group EBITDA Margin %?

UnitedHealth Group LIM:UNH +2.98% 66 EBITDA Margin % is 8.90% as of Mar. 2026, which is 1% below its 10-year median of 9.00. GuruFocus rates LIM:UNH with a GF Score™ of 66/100 and a GF Value™ of $603.41 (Significantly Undervalued). The stock has 10 warning signs investors should review. Among 18 Healthcare Plans companies, UnitedHealth Group ranks better than 55.56% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. UnitedHealth Group's EBITDA for the three months ended in Mar. 2026 was $9,947 Mil. UnitedHealth Group's Revenue for the three months ended in Mar. 2026 was $111,721 Mil. Therefore, UnitedHealth Group's EBITDA margin for the quarter that ended in Mar. 2026 was 8.90%.


UnitedHealth Group  (LIM:UNH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


UnitedHealth Group EBITDA Margin % Related Terms


UnitedHealth Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for UnitedHealth Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UnitedHealth Group EBITDA Margin % Chart

UnitedHealth Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.41 9.82 9.78 7.01 5.15

UnitedHealth Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.28 5.55 4.71 1.21 8.90

LIM:UNH vs CVS, ELV, CI: EBITDA Margin % Comparison

For the Healthcare Plans subindustry, UnitedHealth Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UnitedHealth Group EBITDA Margin % vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, UnitedHealth Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where UnitedHealth Group's EBITDA Margin % falls into.


LIM:UNH
66GF Score
UnitedHealth Group Inc LIM:UNH
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UnitedHealth Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

UnitedHealth Group's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=23060/447567
=5.15 %

UnitedHealth Group's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=9947/111721
=8.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 8.90% mean?
UnitedHealth Group (LIM:UNH) has a EBITDA Margin % of 8.90% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on UnitedHealth Group and its competitors. This is near median its historical median of 9.00. Over the past decade, UnitedHealth Group's EBITDA Margin % has ranged from 5.08 to 9.84. According to the industry distribution chart, UnitedHealth Group ranks #8 out of 18 companies in the Healthcare Plans industry, placing it in the top 44.4%.
Is UnitedHealth Group's EBITDA Margin % too high?
UnitedHealth Group's current EBITDA Margin % of 8.90% is near median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 5.08 to a high of 9.84. The Healthcare Plans industry median EBITDA Margin % is 4.56. UnitedHealth Group's value of 8.90% is 95.4% above this industry median. Based on the distribution chart, UnitedHealth Group ranks #8 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, UnitedHealth Group has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UnitedHealth Group's EBITDA Margin % compare to CVS and ELV?
According to the Healthcare Plans industry distribution chart, UnitedHealth Group ranks #8 out of 18 companies for EBITDA Margin %. This puts UnitedHealth Group in the upper half of its industry. The industry median EBITDA Margin % is 4.56. UnitedHealth Group's value of 8.90% is 95.4% above this benchmark. Historically, UnitedHealth Group's own EBITDA Margin % has ranged from 5.08 to 9.84 over the past decade. While the company's 10-year median is 9.00 vs. the industry median of 4.56, UnitedHealth Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Plans company?
The median EBITDA Margin % among Healthcare Plans companies is 4.56, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UnitedHealth Group's current EBITDA Margin % of 8.90% is 95.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on UnitedHealth Group and its competitors. For the Healthcare Plans industry, the median EBITDA Margin % is 4.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UnitedHealth Group's current EBITDA Margin % is 8.90%, which is near median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnitedHealth Group stock overvalued right now?
Based on GuruFocus' analysis, UnitedHealth Group (LIM:UNH) is currently considered Significantly Undervalued. The stock's GF Value™ is $603.41, compared to a current price of $415.00 — trading 31.2% below its estimated fair value. The current EBITDA Margin % is 8.90%, which is near median its 10-year median of 9.00 and 95.4% above the Healthcare Plans industry median of 4.56. UnitedHealth Group's overall GF Score™ is 66/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For UnitedHealth Group (LIM:UNH), the current EBITDA Margin % is 8.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UnitedHealth Group (LIM:UNH) Overvalued in 2026?

Based on GuruFocus' analysis, UnitedHealth Group stock appears to be undervalued. The current stock price of $415.00 is trading 31.2% below its estimated GF Value™ of $603.41. GuruFocus considers UnitedHealth Group to be Significantly Undervalued.

Key valuation signals for LIM:UNH:

  • EBITDA Margin %: 8.90% (near median its 10-year median of 9.00)
  • GF Value™: $603.41 vs. price of $415.00 (31.2% below fair value)
  • GF Score™: 66/100 with 10 warning signs
  • Industry Position: 95.4% above the Healthcare Plans median (#8 of 18)

No single metric tells the full story. See the LIM:UNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


UnitedHealth Group Business Description

Address 1 Health Drive, Eden Prairie, MN, USA, 55344
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
66GF Score

Get the complete analysis for LIM:UNH

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$415.00
Price
$603.41
GF Value